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Abstract
Objective: Associations of cortisol and depression vary at different life-stages, yet population-based, prospective
studies are scarce. We aimed to assess associations of morning cortisol with depressive symptoms in mid-life taking
account of lifetime psychological health.
Methods: Participants were 5,403 men and women from the 1958 British Birth Cohort whose salivary cortisol was
assessed at 45y (45min after waking (T1) and 3h later (T2)) and who completed the 5-item Mental-Health Index
(MHI-5) about depressive symptoms at age 50y. Lifetime psychological health was identified from child and adult
measures.
Results: For women, higher T2 cortisol at 45y predicted depression (MHI-5 scores ≤52) at 50y (odds ratio [OR]=1.17;
95% confidence intervals [CI] 1.05,1.30 per standard deviation increase in T2 cortisol), attenuating when adjusted for
current (45y) and previous (7-42y) psychological health (OR=1.11; 95% CI 0.98, 1.24). Similarly, an association in
women of flatter cortisol delta (T2-T1) with depressive symptoms at 50y weakened after adjustment for current (45y)
and previous (7-42y) psychological health. For men, lower T2 cortisol at 45y predicted greater depressive symptoms
at 50y and the association strengthened when adjusted for lifetime psychological health. Likewise, lower cortisol AUC
predicted higher risk of depression for men after adjusting for prior psychological health (OR=0.85; CI 0.72, 1.00).
Associations were largely unaltered by control for covariates.
Conclusions: In women, higher cortisol in late morning at 45y is prospectively associated with depressive symptoms
at 50y through a link with lifetime psychological health. In men, lower cortisol predicts subsequent symptoms,
independent of depressive history.
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Introduction
Major depression is the most common mental health
illness[1] and a leading contributor to the global burden of
disease[2]. Hypo- or hyper-activation of the hypothalamic-
pituitary-adrenal (HPA) axis, with cortisol as the primary
hormonal component, is frequently observed amongst
depressed individuals[3]. It is biologically plausible that atypical
secretion of cortisol may confer risk for depression as
glucocorticoid receptors are widely distributed in brain areas
implicated in emotion regulation, notably hippocampus and
amygdala[4]. While HPA activity or cortisol secretion are
suspected to influence the onset of depression, prospective
studies are needed to verify this assumption. Of particular
relevance for the putative role of cortisol on depression at a
specific stage of life, is the growing evidence for an evolving
relationship between cortisol and depression over the life-
course[5]. In longitudinal studies of children and adolescents,
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hyperactivity of the HPA (as indicated by higher cortisol
awakening response (CAR) and higher morning cortisol) has
been shown to predict depression onset and recurrence[6–13].
However, findings from the few longitudinal studies in
adulthood are less consistent, with studies showing that both
lower and higher cortisol levels predict depression
outcome[14–18]. For example, among 55 outpatients remitted
from depression, lower morning cortisol predicted faster
relapse of depression over a 5.5y period [17]. Whilst, in 116
initially not-depressed women (but at high risk for mental health
difficulties) aged 23-58y, elevated morning cortisol at 8.00h
was found to be associated with onset of major depressive
episode in a 1y period[14] and, higher levels of cortisol after
dexamethasone-CRH test predicted relapse in 74 inpatients
remitted from depression[16]. The heterogeneity of adult
studies may reflect the evolving relationship between cortisol
and depression with age. If socio-emotional and HPA-axis
development are co-founded early in life and then continue to
co-evolve, earlier associations should be taken into account in
investigations of cortisol and depression at later life stages.
In contrast to child and adolescent populations, most
depressed adults have already experienced more than one
depressive episode[19]. The literature suggests that exposure
to persistent psychopathology could alter the functioning of the
HPA axis. Time elapsed since the onset of depression appears
to be important in understanding the association between
cortisol (hypo or hyper-secretion) and depression[20]. A few
studies[21], including one based on the 1958 British Birth
Cohort, have suggested that cortisol tends to be high around
the time of depression onset, but lowered when depression
persists for a long time[22]. Therefore, one challenge in
investigating the longitudinal association between cortisol and
depression, especially in adulthood, is to take account of
previous life-course influences on cortisol including depressive
symptoms.
In the present study, we examine whether salivary cortisol at
45y is associated with depressive symptoms at 50y in a
general population sample. Because the association of cortisol
with depression may develop over the life-course; we aim to
investigate whether salivary cortisol is related to subsequent
depression in mid-adulthood through a link with lifetime
emotional status or whether cortisol has a separate
contribution.
Materials and Methods
Participants
The 1958 cohort includes all children born in England,
Scotland, and Wales in 1 week in March 1958. About 17,000
live births were followed-up at ages 7, 11, 16, 23, 33, 42, 45
and 50y[23]. The 45y contact was a clinical examination
undertaken by a trained research nurse; of 11,971 individuals
invited, 9,377 participated. Written informed consent was
obtained from all participants, whilst ethical approval for saliva
collection and clinical examination at 45y was given by the
South East Multi-Centre Research Ethics Committee.
Salivary cortisol at 45y
Participants were asked to collect two saliva samples on the
next convenient day after clinical examination, the first 45min
after awaking before breakfast (time 1 or T1) and the second 3h
later on the same day before lunch (time 2 or T2). Participants
received a Home Saliva Collection Kit (including two numbered
and color-coded salivette tubes, one pre-addressed envelope
and instructions). They were instructed to collect saliva by
chewing on a swab until it was soaked and to record the exact
time of sample collection. Participants were asked to refrain
from brushing or flossing their teeth and eating or drinking
15min before saliva collection and to store the sample at room
temperature until posting to the laboratory. Salivary cortisol is
stable at room temperature for up to 30 days, but samples
were frozen after reaching the laboratory to reduce microbial
growth. Cortisol levels were measured at the University of
Dresden with a commercial chemiluminescence immunoassay
kit (IBL International, Hamburg, Germany). The lower
sensitivity of this assay is 0.44 nmol/L, with intraassay and
interassay precision of <10% for a wide range of cortisol
concentrations. High cortisol levels (>50 nmol/l) were rerun in a
second assay for confirmation.
Cortisol indicators.  Extreme cortisol outliers were
truncated at 2 nmol/l for <2 nmol/l (n=24 at T1, n=122 at T2) and
at 100 nmol/l for >100 nmol/l (n=22 at T1, n=20 at T2) in order
that extreme values did not exert a disproportionate influence
on analyses. Not all samples were collected at the specified
times, leading to variation around the target time for T1 [mean
(S.D.)=49 (15)min] and T2 [mean (S.D.)=3h 5min (27min)].
Cortisol level was influenced by both the time of awakening
and time since awaking, and to take account of this variability
T1 value was centered at 08:08h (45min after a mean waking
time of 07:22h) and T2 at 11:08h (3h 45min after mean
awakening time) based on predictions from linear regression
models at these time points[24]. Cortisol values had a skewed
distribution and therefore were transformed using Log 10. As in
prior publications with this cohort[22,24–27], we analysed
several cortisol measures derived from transformed and
centred values: first, T1 and T2 cortisol levels; second, cortisol
T2 to T1 delta calculated as the difference between T2 and T1
cortisol levels divided by 3h; and third, area-under-the-curve
(AUC), derived as the sum of T1 and T2 cortisol multiplied by 3h
and divided by 2 (thus, AUC represents the 3h average of T1
and T2 values, allowing for variation in collection times, used
here to indicate total 3h exposure). These measures were
further converted into z-scores. Pearson correlation between T1
and T2 cortisol was 0.28, delta correlated at -0.79 with T1 and at
0.38 with T2, and AUC correlated at 0.88 with T1 and at 0.70
with T2, all p<.001.
Cortisol testing conditions.  Information was collected on
whether participants were awake during the previous night
between 24:00 and 06:00, worked at night between 24:00 and
6:00, had dental work within the last 3 days or had cuts or other
damage inside their mouth that may bleed, current medication
affecting cortisol, and the day of the week of cortisol collection
(weekend/weekday). Information on smoking habits (never/ex-/
current smoker) was gathered at 42y. Day of week, current
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medication, smoking habits and night working were associated
with T1 or T2 cortisol, and were controlled in the analyses.
Depressive symptoms outcome at 50y
Participants completed the Mental Health Inventory (MHI-5);
a validated and widely used screening questionnaire for
depression[28]. The 5 self-report items scored on a 6-point
scale ranging from “all” to “none” of the time include: How
much of the time during the last month have you: (1) been a
very nervous person?; (2) felt calm and peaceful?; (3) felt
downhearted and low?; (4) been a happy person; (5) felt so
down in the dumps that nothing cheers you up? The scale was
scored 0-100, with lower scores indicating more severe
symptoms. The MHI-5 has been shown to have high sensitivity
and specificity in detecting clinical depression[29].
Categorical measure.  As in previous studies, MHI-5 scores
≤52 were identified as elevated depressive symptoms
(hereafter referred to as ‘depression’) and scores>52 as not
depressed [30,31].
Continuous measure.  To facilitate interpretation, the
original MHI-5 scale was reversed so that those with the most
severe symptoms had higher scores.
Depressive symptoms (45y)
Symptoms in the past week (persistent sadness/low mood
and/or marked loss of interest/pleasure for ≥4days/week and/or
≥3h/day and/or no reactivity to pleasurable stimuli) were
established with the widely used Clinical Interview Schedule
(CIS-R), administered by a trained nurse visiting during the
clinical examination[32]. Scores range from 0-4 symptoms.
Previous adulthood depressive symptoms (23-42y)
A summary score of adulthood symptoms was calculated as
the mean of psychological malaise scores reported by
participants at ages 23, 33 and 42y. The Psychological
Malaise[33] comprised 15 items covering major components of
depression and anxiety, including depressed mood, sleep
disturbance, fatigue, irritability, excessive worries, and phobias
scored as 0 (no) to 1 (yes). Individual scores at 23, 33, and 42y
were converted into z-scores. A summary score was calculated
for participants with a malaise score at ≥1 age (78.8% had data
at all three ages).
Childhood (7-11y) and adolescent (16y) behaviour
A summary childhood and adolescent behaviour problems
score was calculated as the mean of internalizing and
externalizing behaviours scores as assessed by teachers using
the Bristol Social Adjustment Guide (BSAG) at 7 and 11y[34]
and by the Rutter Behaviour Scale at 16y[35]. The BSAG
consists of 146 behaviour-items assessing 12 syndromes,
grouped into internalizing (items such as miserable, fearful)
and externalizing (e.g. resentful/aggressive, bullies) scores,
participants had a score of 1 if an item applied and 0 if it did not
apply. The Rutter Scale consists of 26 behaviour-items, five of
which were used to derive an internalizing score (e.g. worries,
solitary, miserable) and nine for an externalizing score (e.g.
destructive, irritable, disobedience, fighting); participants had a
score of 2 if an item applied ‘definitely’, 1 for ‘somewhat’ and 0
if it did not apply. Individual scores at 7, 11, and 16y were
converted into z-scores. A summary score was calculated for
participants with a behaviour score at ≥1 age (64.7% had data
at all three ages).
Covariates
Several covariates were examined, including socio-economic
position (SEP) in childhood and in adulthood, birth-weight,
body mass index (BMI; at 45y), cholesterol (45y), hypertension
(45y), post-menopausal status (45y), limiting illness (42y),
heavy drinking (45y), physical activity (42y), childhood and
adulthood adversity. We controlled for those associated with
both cortisol exposure (T1 or T2) and depressive symptoms
(categorical measure): childhood SEP (based on father’s social
class at birth or 7y if missing: I/II, IIINM, IIIM, IV/V) and
adulthood SEP (from participant’s class at 42y or 23-33y if
missing: I/II, IIINM, IIIM, IV/V), BMI (measured weight in
kilograms divided by squared height in meters), limiting long-
term illness (no/yes) and childhood and adulthood adversity.
For childhood adversity, participants answered confidential
questions at 45y, about their childhood to age 16y, from the
Path Through Life Project[36] including abuse by a parent
(physical, sexual, psychological), witnessing intimate partner
violence and neglect by a parent (neglect, lack of father or
mother affection). A categorical score (0, 1, 2, or ≥3) was
created by counting the reports of adversities[24]. For adult
adversity at 45y, participants reported whether they had
experienced (yes/no) during the preceding six months any of
the following life events: serious illness/injury/assault to you or
close friend/relative; death of a family member or relative/
friend; separation or divorce; crisis or serious disappointment at
work; sacked from work, thought of losing job soon;
unemployed/seeking work for >1 month; major financial crisis;
problem with police and court appearance; something valued
was lost or stolen. A categorical score (0, 1, 2, or ≥3) was
created by summing stressful life events experienced.
STATISTICAL ANALYSES
The main analyses examined associations between morning
cortisol indicators (T1, T2, delta T2-T1, AUC) at 45y and
depressive symptoms at 50y, using logistic regression for the
categorical (MHI-5 score ≤52 versus >52) outcome and linear
regression for the continuous outcome (reversed-score with
higher values indicating more severe symptoms and
transformed to z-score to ease interpretation) using robust
standard errors to account for the skewed distribution of MHI-5.
Models for depressive symptoms (categorical and continuous)
were adjusted for cortisol testing conditions (model 1); 45y
depressive symptoms (model 2), previous adulthood (23-42y)
depressive symptoms and childhood/adolescent (7-16y)
behavioural problems (model 3); and other covariates (model
4). We tested whether associations between cortisol and
depressive symptoms (categorical outcome) differed for men
and women using an interaction term for sex.
To illustrate associations between cortisol levels and the
course of depressive symptoms, 45y to 50y, we created a 4-
category variable by cross-classifying presence or absence of
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symptoms at 45y (with a cut-off of ≥2 symptoms on the CIS-
R[32]) and 50y (MHI-5 score ≤52). “Not depressed”, the
reference category, included participants with low symptoms
level at 45 and 50y (i.e. CIS-R score <2 and MHI-5 score >52);
“remitted” included those with a CIS-R score ≥2 and MIH-5
score >52; “incident” included a CIS-R score <2 and MHI-5
score ≤52; “persistent” included individuals with elevated
symptoms at both 45 (CIS-R score ≥2) and 50y (MHI-5 score
≤52). We estimated the geometric mean for T1 and T2 cortisol
adjusted for all covariates using analyses of covariance
(ANCOVA) with type III sum of squares. Statistical differences
in adjusted geometric means for each category (remitted/
incident/persistent symptoms) versus “not depressed” were
estimated for T1 and T2 cortisol and tested using Bonferonni
correction.
Eligible participants for this study included those with MHI-5
data at 50y (n=8762); information on cortisol was available for
5403 of these participants (62% of 8762), of whom 826 had
incomplete information on covariates. To assess whether our
findings were affected by sample attrition between ages 45y
and 50y or missing data, we conducted three separate
analyses. First, we used multiple imputation by chained
equations methods to impute missing values on covariates for
826 participants (but not on exposure or outcome). We created
10 datasets, and conducted regression analyses that combined
results from these datasets. Second, we applied inverse
probability weighting relative to surviving cohort members
resident in the UK by 31st May 2009. The probability of being in
the study sample was estimated from logistic regressions using
factors associated with sample attrition including sex, SEP at
birth, math scores and internalizing and externalizing behaviors
at 7y[37]. Third, we repeated analyses using the sample with
complete data. The pattern of results was similar for complete
data (n=4577), weighted (n=4504) and imputed analyses
(n=5403); the latter are presented here to maximize number of
participants.
Results
Table 1 presents a description of the study sample on key
variables for men and women separately. Table 2 shows that
T1 cortisol was lower and T2 cortisol elevated, although not
always significantly, for the depressed group at different life-
stages compared to others. Table 3 shows results from logistic
and linear regressions assessing prospective associations of
cortisol at 45y with depressive symptoms (categorical and
continuous) at 50y. Some interaction terms were found
(p<0.05, Table 3), hence analyses were conducted separately
for men and women. For women, with adjustment for testing
conditions only, elevated T2 cortisol was associated with
depressive symptoms (odds ratio [OR]=1.17; 95% confidence
intervals [CI] 1.05, 1.30 for categorical outcome; β=0.07, p=.
019 for continuous outcome). Adjustment for current (45y) and
previous psychological health (7-42y) weakened these
associations (OR=1.11; CI 0.98, 1.24, p=.091 for categorical
outcome; β=0.03, p=.227 for continuous outcome). Similarly,
an association of flatter cortisol delta with depressive
symptoms at 50y, weakened after adjustment for 45y
symptoms and was then abolished with further adjustment for
earlier psychological health. For men, T2 cortisol was not
associated with depressive symptoms at 50y in models
adjusted only for testing conditions, but the association
strengthened after taking account of lifetime psychological
health (OR=0.85; CI 0.71, 1.02, p=.075 for categorical
outcome; β=-0.04, p=.008 for continuous outcome) and
remained after controlling for covariates. A similar pattern of
association was detected for cortisol AUC, with highest risk of
subsequent depressive symptoms for men with lower AUC
(OR=0.85; CI 0.72, 1.00, p=.050 for categorical outcome;
β=-0.02, p=.095 for continuous outcome) evident after
adjusting for prior psychological health. Figure 1 presents fully
adjusted T2 cortisol values for depressive symptoms groups
(remitted/incident/persistent vs not depressed). In men, T2
cortisol levels were lower for incident symptoms versus not
depressed (adjusted geometric mean=6.34 (95% CI 5.80,6.93)
vs 7.22 (7.03,7.41), p=.007) but not for remitted or persistent
symptoms. In women, T2 cortisol levels were higher for
persistent depressive symptoms versus not depressed
(adjusted geometric mean=8.29 (95% CI 7.32,9.39) vs 6.67
(6.53,6.82), p=.001) but not for remitted or incident symptoms.
Finally, there was no prospective association of T1 cortisol with
depressive symptoms for men or women (Table 3) and no
difference in adjusted T1 cortisol between 45-50y symptom
groups (remitted/incident/persistent vs not depressed; data not
shown).
Discussion
Our main finding is that naturally occurring cortisol levels at
45y predicted subsequent depressive symptoms at 50y in both
sexes, but with contributions of lifetime psychological health
that differed in their impact for men and women. To the best of
our knowledge, this is the first epidemiological study to show
this. For women, higher late-morning cortisol (T2) at 45y
predicted depressive symptoms at 50y. The association was
abolished when taking account of current and past
psychological health, because high T2 cortisol was associated
with persistent depression at 50y. For men, lower late-morning
cortisol (T2) at 45y predicted depressive symptoms at 50y. The
association strengthened when allowance was made for earlier
psychological health, because low T2 cortisol levels predicted
incident depressive symptoms subsequently at 50y.
Methodological considerations
Data for the 1958 British Birth Cohort, including repeated
assessments of depressive symptoms over the life-course,
provided an opportunity to examine the longitudinal relationship
from cortisol to depression in the general population. Previous
longitudinal studies have relied on small or selected (e.g. high
neuroticism trait) samples or psychiatric participants, limiting
generalisation of findings. Furthermore, unlike previous studies
relying predominantly on female populations, we were able to
investigate the association between cortisol and depressive
symptoms in men. The inclusion of several key covariates,
such as childhood and adulthood adversities, is a further
strength of the study. However, there are several study
Salivary Cortisol and Depression
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limitations. First, the MHI-5 is a validated screening
questionnaire rather than a clinical depression diagnostic
Table 1. Description of the 1958 British Birth Cohort on key
characteristics (n=5403).
 Men Women
 (n=2576) (n=2827)
Salivary cortisol at 45y, mean (s.d.)a   
T1 cortisol (nmols/l) (T1) (2 to 100) 20.86 (11.51) 21.58 (11.39)
T2 cortisol (nmols/l) (T2) (2 to 100)c 8.91 (8.22) 7.97 (6.72)
Delta from T2 to T1 (-31 to 29 nmols/l) -3.99 (3.97) -4.54 (4.04)
AUC (range 6 to 300 nmols/l) 44.66 (24.10) 44.33 (21.34)
Depressive symptoms at 50y   
Depressed (MHI-5≤52) % (n) 9.7 (249) 12.5 (354)
Mean (s.d) reversed scores (0 to 100) 22.44 (16.73) 24.90 (17.56)
Depressive symptoms at 45y   
Depressed (CIS-R≥2) % (n) 7.1 (182) 8.2 (232)
Mean (s.d) scores (range 0 to 4) 0.25 (0.71) 0.29 (0.74)
Previous psychological health covariates, mean
(s.d.)   
Adulthood depressive symptoms (23-42y) (-0.93 to
4.46) -0.24 (0.68) 0.06 (0.83)
Childhood behavioural problems (7-16y) (-1.78 to
2.92) -0.05 (0.58) -0.21 (0.49)
Course of depressive symptoms between
45-50y, % (n)   
Not depressed between 45-50y (CIS-R<2 and
MHI-5>52) 85.4 (2199) 82.0 (2317)
Remitted (CIS-R≥2 and MHI-5>52) 5.0 (128) 5.5 (156)
Incident (CIS-R<2 and MHI-5≤52) 7.6 (195) 9.8 (218)
Persistent (CIS-R≥2 and MHI-5≤52) 2.1 (54) 2.7 (76)
Other covariates, % (n)   
Father's SEP at birth   
I & II 20.8 (537) 20.9 (592)
IIInm 11.1 (287) 10.3 (290)
IIIm 47.7 (1228) 48.0 (1358)
IV & V 20.3 (524) 20.8 (587)
SEP in adulthood at 42y   
I & II 47.8 (1231) 38.0 (1075)
IIInm 10.0 (258) 34.2 (968)
IIIm 30.8 (793) 7.1 (200)
IV & V 11.4 (294) 20.7 (584)
Limiting illness at 42y   
No 89.1 (2294) 88.4 (2500)
Yes 10.9 (282) 11.6 (327)
Childhood adversity by 16y   
None 82.6 (2129) 79.0 (2232)
1 10.6 (272) 10.5 (296)
2 3.6 (93) 5.1 (145)
≥ 3 3.2 (82) 5.4 (154)
Adulthood adversity at 45y   
None 51.4 (1323) 50.5 (1428)
1 26.3 (677) 28.1 (794)
2 12.7 (328) 12.5 (354)
≥ 3 9.6 (248) 8.9 (251)
BMI at 45y (kg/m2) (16.53 to 64.67), mean (s.d.) 27.81 (4.35) 26.81 (5.53)
tool[28] and thus, identifies individuals with elevated symptoms;
a mixture of subclinical, minor and major depression. However,
emerging evidence suggests that the association of cortisol
and depression is not confined to clinical depression, but
extends to the broader range of symptoms[12,38,39]. Second,
our 4-category variable for depressive symptoms 45 to 50y is
imperfect, being based on different instruments (CIS-R and
MHI-5) and change in symptoms between the 45 and 50y
measurements may have been missed. Third, our cortisol
indicators, based on two morning samples during 1 day, might
not adequately capture an individual’s secretion level.
Additional cortisol samples during the day or night would better
indicate naturally occurring secretion patterns. It has been
reported previously that afternoon cortisol or cortisol collected
throughout the day produces a larger effect size with
Table 1 (continued).
Abbreviation: BMI, body mass index, CIS-R, clinical interview schedule-revised,
MHI-5, mental health index- 5 items, SEP, socioeconomic position, S.D., standard
deviation.
P-values for sex difference for T1=.022; for T2=<.001; for delta=<.001; for AUC=.
600; for depressive symptoms at
50y= <.001; for depressive symptoms at 45y=.038; for adulthood depressive
symptoms=<.001; for childhood behavioural problems=<.001; for course of
depressive symptoms between 45-50y=<.001; for SEP at birth=.860; for SEP at
42y=<.001; for limiting illness at 42y=.230; for childhood adversity by 16y=<.001;
for adulthood adversity at 45y=.330; for BMI at 45y=<.001.
doi: 10.1371/journal.pone.0077603.t001
Table 2. Mean (geometric) T1 and T2 cortisol valuesa by
depressive symptoms over the life-course (n=5403).
Depressive symptoms Men (n=2576)  Women (n=2827)  
 T1 T2 T1 T2
 Geometric mean
Subsequent symptoms (50y)         
Depressed 18.25  7.18 † 19.04  6.67 ***
Not depressed 17.37  6.72  17.97  7.46  
Current symptoms (45y)         
Depressed 18.14  7.12  18.91  6.70 **
Not depressed 18.50  7.33  18.88  7.52  
Previous adult symptoms (23-42y)#        
Depressed 18.18  7.07 ** 19.15 ** 6.71 †
Not depressed 17.90  8.24  17.41  7.12  
Previous childhood symptoms (7-16y)#        
Behaviour problems 18.17  7.08  18.96  6.76  
No behaviour problems 18.13  7.34  18.20  6.86  
***. p≤.001
**. p<.01
†. p<.10
#. For the purposes of illustration, adult symptoms (23-42y) and childhood (7-16y)
behavioural problems were categorized as below (not depressed) and above
(depressed) the 10th percentile.
doi: 10.1371/journal.pone.0077603.t002
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depression than morning cortisol measures[40]. Further,
samples collected at earlier life-stages would inform
understanding of the lifetime co-evolution of cortisol and
psychological health. Fourth, although we controlled for
numerous covariates, the possibility of unmeasured
confounding remains.
Table 3. Association between cortisol at 45y and
depressive symptoms at 50y (n=5403).
 Men (n=2576) Women (n=2827)
 
Depressed vs
not depressed Symptomsa  
Depressed vs not
depressed Symptomsa  
 OR (95% CI) B (SE)  OR (95% CI)  B (SE)  
Cortisol indicators at 45y (z-score)a      
T1
Cortisol        
Model 1 0.89(0.77,1.03) 0.00 (0.02)  
0.94
(0.83,1.06)  -0.02 (0.02)  
Model 2 0.89 (0.77,1.03) 0.00 (0.02)  
0.93
(0.83,1.06)  -0.01 (0.02)  
Model 3 0.89 (0.76,1.04) 0.00 (0.02)  
0.98 (0.86,
1.11)  0.00 (0.02)  
Model 4 0.90 (0.77,1.05) -0.01 (0.02)  
0.99
(0.88,1.13)  0.00 (0.02)  
T2
Cortisol        
Model 1 0.89 (0.76,1.05) -0.02 (0.02)  
1.17
(1.05,1.30) ** 0.07 (0.03) *
Model 2 0.88 (0.75,1.03) -0.03 (0.02) †
1.14
(1.02,1.28) * 0.05 (0.03) *
Model 3 0.85 (0.71,1.02) -0.04 (0.02)
*
*
1.11
(0.98,1.24) † 0.03 (0.02)  
Model 4 0.84 (0.71,1.01) -0.04 (0.02)
*
*
1.11 (0.98,
1.26) † 0.03 (0.02)  
Delta (T2-T1/3h)       
Model 1 1.04 (0.90,1.19) -0.01 (0.02)  
1.17
(1.05,1.31)  0.05 (0.02) *
Model 2 1.02 (0.89,1.18) -0.02 (0.02)  
1.15 (1.03,
1.29)  0.04 (0.02) *
Model 3 1.01 (0.88,1.16) -0.02 (0.02)  
1.09 (0.96,
1.22)  0.01 (0.02)  
Model 4 1.00 (0.86,1.15) -0.02 (0.02)  
1.07 (0.95,
1.21)  0.01 (0.02)  
AUC        
Model 1 0.87 (0.75,1.01) -0.01 (0.02)  
1.04 (0.92,
1.17)  0.02 (0.02)  
Model 2 0.86 (0.74,1.01) -0.02 (0.02)  
1.02 (0.90,
1.15)  0.01 (0.02)  
Model 3 0.85 (0.72,1.00) -0.02 (0.01)  
1.04 (0.92,
1.17)  0.01 (0.02)  
Model 4 0.85 (0.72,1.00) -0.02 (0.01) †
1.05 (0.93,
1.19)  0.02 (0.02)  
Interpretation of findings
Our findings indicate that consideration of lifetime
psychological health is essential to understand the relationship
between cortisol level and subsequent depressive symptoms in
mid-life. This is consistent with the suggestion that chronic
stress or psychopathology may initially be associated with
heightened cortisol response, but over time the HPA axis may
be down-regulated and lead to attenuation of the cortisol
response [20,21,41]. Such changes over the life-course can
obscure the association of cortisol with depression, especially
in adult life when individuals may have had a cumulative
exposure to depression and/or when effects of cortisol may be
over-shadowed by more dominant influences on depression,
such as relationship or job loss. For women in our study, the
abolition of an association of 45y cortisol with subsequent (50y)
depressive symptoms that resulted from adjustment for
symptom history is likely to reflect associations from earlier in
life that persist through to ages 45-50y. However, our results
showing that associations between cortisol at 45y and
depressive symptoms at 50y were dependent on previous
psychological health contradicts the findings of another study.
Harris and al[14]. reported that elevated morning cortisol
increased the risk of subsequent depression in adult women by
1.3 times independently of previous mental illness; their
assessment of mental health history was retrospective and
therefore less reliable than our prospective assessment.
Associations of cortisol secretion with depressive symptoms
in men have been largely neglected in the literature. While
depression disproportionally affects women from the beginning
to the end of reproductive life[42], men are more prone to
depression with advancing age[43]; our findings suggest that a
blunted morning cortisol pattern is a precursor to their mid-life
depression. When we took account of lifetime psychological
health trajectories, men with lower late morning cortisol levels
at 45y were more likely to have onset of depressive symptoms
by 50y. Associations between low basal cortisol and
Table 3 (continued).
Abbreviation: OR, odds ratio; CI, confidence intervals; SE, standard error.
a Reversed.
Model 1 adjusted for testing conditions: day (weekday/weekend) of cortisol
collection, medication at 45y (no/yes), night work at 45y (no/yes), smoking at 42y
(never/ex/current).
Model 2 adjusted for baseline depressive symptoms at 45y.
Model 3 adjusted for lifetime psychological health: summary score for
externalizing/internalizing problems in childhood (7-16y), summary sore for
psychological Malaise in adulthood (23-42y).
Model 4 adjusted for other covariates: lifetime social class (I&II/IIINM/IIIM/
IV&IV),BMI at 45y, limiting illness at 42y (no/yes), childhood and adulthood life-
adversity (0/1/2/≥3).
**. p<.01
*. p<.05
†. p<.10
P-values for sex interaction for t1=.623; for t2=.006; for delta =.187; for AUC=.075
(calculated from model 1 with categorical depression outcome).
doi: 10.1371/journal.pone.0077603.t003
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depression have been reported elsewhere. For example, in 152
(133 men) patients who had survived an acute coronary
episode, blunted cortisol awakening response was associated
with current depression, taking account of previous depression
and other factors[44].
Another interesting finding of our study is that late-morning
(T2), but not early morning (T1) cortisol was predictive of
subsequent symptoms at 50y. Previously we showed, within
this cohort, that elevated T2 cortisol (but not T1) at 45y
predicted worse cognition at 50y . In childhood and
adolescence, many studies reported that higher cortisol
awakening response or early morning cortisol predicts
depression onset and recurrence[6–9,11–13], whereas the very
few prospective studies on cortisol and depression in adulthood
show discrepant findings[14–17]. Whilst findings in the
literature appear contradictory, they highlight the likelihood that
associations of cortisol and mental health vary at different life-
stages and by sex. Furthermore, there is no agreement in the
literature on the specific component(s) of cortisol diurnal profile
that indicates risk for later outcome and, as far as we are
aware, the predictive role of late morning cortisol for outcomes
has received little attention.
Conclusions
Naturally occurring cortisol was longitudinally associated with
depressive symptoms in our large community sample of
middle-aged adults, with earlier depressive symptoms
contributing to this association. In women, associations
between elevated cortisol and depressive symptoms appeared
to develop before mid-life. This was the first study to find that,
in men, blunted late-morning cortisol may precede the onset of
depressive symptoms, 5y later. Future studies with repeated
measurements of cortisol and depressive symptoms are
needed to clarify further the temporality of the evolving HPA-
axis and related mental health history.
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